| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82737-073-01 | 82737-073 | HUMAN PRESCRIPTION DRUG | Aphexda | Motixafortide | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | SUBCUTANEOUS | 20230908 | N/A | NDA | NDA217159 | BioLineRx USA Inc | MOTIXAFORTIDE ACETATE | 62 mg/1.7mL | 1 VIAL, GLASS in 1 CARTON (82737-073-01) / 1.7 mL in 1 VIAL, GLASS |
| 73441-062-01 | 73441-062 | HUMAN PRESCRIPTION DRUG | APHEXDA | MOTIXAFORTIDE | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | SUBCUTANEOUS | 20250615 | N/A | NDA | NDA217159 | Gamida Cell Inc. | MOTIXAFORTIDE ACETATE | 62 mg/1.7mL | 1 VIAL, GLASS in 1 CARTON (73441-062-01) / 1.7 mL in 1 VIAL, GLASS |